Publications by authors named "Mark D Starr"

Claim this Profile
P
Prognostic and predictive analyses of circulating plasma biomarkers in men with metastatic castration resistant prostate cancer treated with docetaxel/prednisone with or without bevacizumab.
Andrew B Nixon, Yingmiao Liu, Qian Yang, Bin Luo, Mark D Starr

Prostate Cancer Prostatic Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study investigating the effect of pembrolizumab on the tumoral immunoprofile of newly diagnosed mullerian cancers.
Stéphanie L Gaillard, Gloria Broadwater, Andrew Berchuck, William S Andrews, Laura J Havrilesky, Mark D Starr

Gynecol Oncol Rep· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy Participants.
Yingmiao Liu, Jiatong Li, Jing Lyu, Lauren E Howard, Alexander B Sibley, Mark D Starr

Cancer Epidemiol Biomarkers Prev· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating immune biomarkers correlating with response in patients with metastatic renal cell carcinoma on immunotherapy.
Joyce Hwang, Eda Holl, Yuan Wu, Anika Agarwal, Mark D Starr

JCI Insight· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycosaminoglycan modifications of betaglycan regulate ectodomain shedding to fine-tune TGF-β signaling responses in ovarian cancer.
Alex S Choi, Laura M Jenkins-Lane, Wade Barton, Asha Kumari, Carly Lancaster, Mark D Starr

Cell Commun Signal· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heparan sulfate modifications of betaglycan promote TIMP3-dependent ectodomain shedding to fine-tune TGF-β signaling.
Alex S Choi, Laura M Jenkins-Lane, Wade Barton, Asha Kumari, Carly Lancaster, Mark D Starr

bioRxiv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance).
Andrew B Nixon, Susan Halabi, Yingmiao Liu, Mark D Starr, John C Brady

Clin Cancer Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance).
Andrew B Nixon, Alexander B Sibley, Yingmiao Liu, Ace J Hatch, Chen Jiang, Mark D Starr

Clin Cancer Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancer.
Zainab Shonibare, Mehri Monavarian, Kathleen O'Connell, Diego Altomare, Abigail Shelton, Mark D Starr

Cell Rep· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating immune response and metabolic related biomarkers pre-allogenic hematopoietic stem cell transplant in acute myeloid leukemia.
Sharareh Siamakpour-Reihani, Felicia Cao, Jing Lyu, Yi Ren, Andrew B Nixon, Mark D Starr

PLoS One· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabozantinib with or without Panitumumab for RAS wild-type metastatic colorectal cancer: impact of MET amplification on clinical outcomes and circulating biomarkers.
Jingquan Jia, Lauren Howard, Yingmiao Liu, Mark D Starr, John C Brady

Cancer Chemother Pharmacol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot investigation of circulating angiogenic and inflammatory biomarkers associated with vascular malformations.
Sarah E Wetzel-Strong, Shantel Weinsheimer, Jeffrey Nelson, Ludmila Pawlikowska, Dewi Clark, Mark D Starr

Orphanet J Rare Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and Predictive Biomarkers in Patients with Metastatic Colorectal Cancer Receiving Regorafenib.
Yingmiao Liu, Jing Lyu, Kirsten Bell Burdett, Alexander B Sibley, Ace J Hatch, Mark D Starr

Mol Cancer Ther· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218.
Angeles Alvarez Secord, Kirsten Bell Burdett, Kouros Owzar, David Tritchler, Alexander B Sibley, Mark D Starr

Clin Cancer Res· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of nintedanib in patients with bevacizumab-resistant recurrent epithelial ovarian, tubal, and peritoneal cancer.
Angeles Alvarez Secord, Michael McCollum, Brittany A Davidson, Gloria Broadwater, Robert Squatrito, Mark D Starr

Gynecol Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of Circulating Protein Biomarkers in Cancer Patients Receiving Bevacizumab and the Anti-Endoglin Antibody, TRC105.
Yingmiao Liu, Mark D Starr, John C Brady, Christel Rushing, Herbert Pang

Mol Cancer Ther· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot Evaluation of Angiogenesis Signaling Factor Response after Transcatheter Arterial Embolization for Hepatocellular Carcinoma.
James Ronald, Andrew B Nixon, Daniele Marin, Rajan T Gupta, Gemini Janas, Mark D Starr

Radiology· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3.
Rachel A Hesler, Jennifer J Huang, Mark D Starr, Victoria M Treboschi, Alyssa G Bernanke

Carcinogenesis· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood-based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance).
Ace J Hatch, Alexander B Sibley, Mark D Starr, J Chris Brady, Chen Jiang

Cancer Med· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker signatures correlate with clinical outcome in refractory metastatic colorectal cancer patients receiving bevacizumab and everolimus.
Yingmiao Liu, Mark D Starr, John C Brady, Christel Rushing, Anuradha Bulusu

Mol Cancer Ther· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors.
Hope E Uronis, Jingquan Jia, Johanna C Bendell, Leigh Howard, Neal A Ready, Mark D Starr

Cancer Chemother Pharmacol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase Ib study of combined VEGFR and mTOR inhibition with vatalanib and everolimus in patients with advanced renal cell carcinoma.
Rhonda L Bitting, Patrick Healy, Patricia A Creel, James Turnbull, Karla Morris, Mark D Starr

Clin Genitourin Cancer· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stromal heparan sulfate differentiates neuroblasts to suppress neuroblastoma growth.
Erik H Knelson, Angela L Gaviglio, Jasmine C Nee, Mark D Starr, Andrew B Nixon

J Clin Invest· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of circulating protein biomarkers following TRC105 (anti-endoglin antibody) treatment in patients with advanced cancer.
Yingmiao Liu, Mark D Starr, John C Brady, Andrew Dellinger, Herbert Pang

Cancer Med· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The balance of cell surface and soluble type III TGF-β receptor regulates BMP signaling in normal and cancerous mammary epithelial cells.
Catherine E Gatza, Jennifer L Elderbroom, Sun Young Oh, Mark D Starr, Andrew B Nixon

Neoplasia· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis